HBCHRC Punjab conducts first allogeneic stem cell transplant
17-year-old sister donates bone marrow to save life of 10-year-old brother battling cancer
Hospital facilitated over Rs 14 lakh in financial assistance, besides arranging accommodation for the family in Dharamshala: Director Dr Ashish Gulia
New Chandigarh 15 September ( Ranjeet Singh Dhaliwal ) : A 17-year-old girl donated her stem cells to give her 10-year-old brother a second chance at life after he battled leukemia, a type of blood cancer, as Homi Bhabha Cancer Hospital and Research Centre (HBCH&RC), New Chandigarh, successfully conducted its first allogeneic bone marrow transplant (BMT). The 10-year-old boy, a resident of Durgapur, West Bengal, was diagnosed with a second relapse of acute lymphoblastic leukemia (ALL)in April this year. The family travelled to Punjab to continue his treatment at HBCH&RC, a unit of Tata Memorial Centre under the Department of Atomic Energy (Government of India). Following intensive chemotherapy, he achieved remission. However, considering the high risk of reoccurrence, an allogeneic stem cell transplant was recommended as the best curative treatment.
An allogeneic bone marrow transplant, also called a stemcell transplant, is a treatment in which a patient’s diseased blood-formingsystem (bone marrow) is replaced with healthy blood-forming stem cells obtainedfrom another person. “Thepatient’s elder sister was identified as the most suitable donor after detailed donor evaluation. Her stem cells were collected and infused into her brother through a vein. The transplanted cells successfully engrafted and, following close monitoring and supportive care, the child has now recovered and was discharged from the hospital, in good health, onTuesday. We will continue to closely monitor him during the post-transplant period”, saidPediatric Hematologist-Oncologist and BMT physician, Dr Jasmeet Sidhu.“Transplantations requires meticulous planning, precise donor selection, infection prevention and intensive supportive care. The hospital’s medical oncology department, with a dedicated Paediatric oncology unit, is equipped with modern treatment facilities like monoclonal antibodies, Chimeric Antigen Receptor T-cell (CAR-T) therapy, immunotherapies and targeted therapies for adult and paediatric patients. It is pertinent to mention that the treatment here is highly subsidized,” head of the department of medical oncology, Dr Seema Gulia, said.
Director, HBCH &RC Punjab, Dr Ashish Gulia, said, “For us, this is not only a medical milestone but a deeply human one. This story of young brother and sister, shows the hope that advanced cancer care can offer to families facing some of the most difficult moments of their lives. We ensured that the patient’s family is supported medically, emotionally, as well as financially. The hospital’s Medical Social Work team facilitated over ₹14 lakh in financial assistance through government schemes and CSR support, besides arranging accommodation for the family in Dharamshala during treatment.”
“Since the inception of BMT programme in 2024, the hospital has performed 15 stem cell transplants and three CAR-T cell therapy infusions, so that patients with difficult-to-treat blood cancers can access potentially curative treatment. We are committed in providing world-class cancer treatment at affordable cost, in entire North India”, Dr Gulia added.

Comments
Post a Comment